CVS HEALTH CORPORATION REPORTS THIRD QUARTER 2026 RESULTS AND RAISES FULL-YEAR 2026 GUIDANCE

The Quick Take
Third quarter total revenues increased to $108.4 billion, up 5.4% year-over-year Third quarter GAAP diluted EPS of $1.68 and Adjusted EPS of $2.09 Generated year-to-date cash flow from operations of $15.3 billion Raising full-year 2026 guidance:GAAP diluted EPS guidance to at least $6.98...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Local
Newly Elected To Senate, Talarico Plans To Work With Trump On Federally Legalizing Marijuana
After becoming the first Democrat elected to the U.S. Senate from Texas in decades, James Talarico plans to work with President Donald Trump on federally…
Business
Robbins LLP Urges BULL Investors to Contact the Firm for Information About the Webull Corporation Securities Class Action Lawsuit
SAN DIEGO, Nov. 4, 2026 /PRNewswire/ -- Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of persons or…
Business
Mach Travel Solutions Limited Records Highest-Ever H1 Revenue in FY27 with Strong PAT
NEW DELHI, Nov. 4, 2026 /PRNewswire/ -- Mach Travel Solutions Limited (BSE: MACHLTD), formerly Mach Conferences & Events Limited, announced its unaudited…
Business
Une étape majeure pour la biométrie des empreintes digitales sans contact : DERMALOG se qualifie pour le prestigieux programme NIST FastCAP
La qualification réussie de DERMALOG au programme NIST FastCAP marque une avancée importante dans la biométrie des empreintes digitales sans contact et permet…
